{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:48:23Z","timestamp":1791082103224,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2021FZZX001-44"],"award-info":[{"award-number":["2021FZZX001-44"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017599","name":"Science and Technology Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2024C03159"],"award-info":[{"award-number":["2024C03159"]}],"id":[{"id":"10.13039\/501100017599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2704200"],"award-info":[{"award-number":["2022YFC2704200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2704203"],"award-info":[{"award-number":["2022YFC2704203"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072858"],"award-info":[{"award-number":["82072858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273348"],"award-info":[{"award-number":["82273348"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031028","name":"Rajavithi Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.isci.2025.112617","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T02:40:37Z","timestamp":1746758437000},"page":"112617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Multi-analyte approach combining cfDNA sequencing and protein testing for early ovarian cancer detection"],"prefix":"10.1016","volume":"28","author":[{"given":"Fenfen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoqun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senmi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuyan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-7261","authenticated-orcid":false,"given":"Xiaodong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.112617_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.isci.2025.112617_bib2","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1002\/cncr.32595","article-title":"Biomarkers in ovarian cancer: To be or not to be","volume":"125","author":"Arend","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.isci.2025.112617_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.isci.2025.112617_bib4","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/cancers12030768","article-title":"30 Years of Experience in the Management of Stage III and IV Epithelial Ovarian Cancer: Impact of Surgical Strategies on Survival","volume":"12","author":"Delga","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2025.112617_bib5","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210117","article-title":"The role of CT, PET-CT, and MRI in ovarian cancer","volume":"94","author":"Engbersen","year":"2021","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.isci.2025.112617_bib6","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1158\/1055-9965.EPI-20-1057","article-title":"Biomarkers and Strategies for Early Detection of Ovarian Cancer","volume":"29","author":"Bast","year":"2020","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.isci.2025.112617_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2217\/17520363.1.4.513","article-title":"CA125 in ovarian cancer","volume":"1","author":"Scholler","year":"2007","journal-title":"Biomark. Med."},{"key":"10.1016\/j.isci.2025.112617_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2017.10.015","article-title":"Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival","volume":"87","author":"Temkin","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.isci.2025.112617_bib9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s13277-014-2738-7","article-title":"Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women","volume":"36","author":"Fujiwara","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.isci.2025.112617_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2016.01.016","article-title":"HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study","volume":"141","author":"Romagnolo","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3892\/br.2016.682","article-title":"The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer","volume":"5","author":"Wei","year":"2016","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.isci.2025.112617_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ygyno.2022.05.025","article-title":"Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?","volume":"166","author":"Lof","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib13","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2174\/1389450121666200425211732","article-title":"Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer?","volume":"21","author":"El Bairi","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.isci.2025.112617_bib14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.31557\/APJCP.2019.20.4.1103","article-title":"Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses","volume":"20","author":"Dewan","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.isci.2025.112617_bib15","first-page":"457","article-title":"Diagnostic performances of CA125, HE4, and ROMA index in ovarian cancer","volume":"36","author":"Dikmen","year":"2015","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib16","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1515\/cclm-2011-0477","article-title":"Diagnostic value of HE4 for ovarian cancer: a meta-analysis","volume":"50","author":"Yu","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.isci.2025.112617_bib17","article-title":"Profiling the metabolome of uterine fluid for early detection of ovarian cancer","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.112617_bib18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.annonc.2021.01.074","article-title":"Exosome-based liquid biopsies in cancer: opportunities and challenges","volume":"32","author":"Yu","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1158\/1940-6207.CAPR-19-0184","article-title":"Reducing Ovarian Cancer Mortality Through Early Detection: Approaches Using Circulating Biomarkers","volume":"13","author":"Trinidad","year":"2020","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.isci.2025.112617_bib20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Diaz","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2147\/CMAR.S155693","article-title":"Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors","volume":"10","author":"Chen","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.isci.2025.112617_bib22","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1186\/s12885-021-08682-y","article-title":"Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient\u2019s plasma - a prospective trial","volume":"21","author":"Hasenburg","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2025.112617_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ygyno.2018.03.050","article-title":"A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma","volume":"149","author":"Han","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.annonc.2019.11.014","article-title":"Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer","volume":"31","author":"Moss","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib25","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2025.112617_bib26","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2015.61.3083","article-title":"Lavage of the Uterine Cavity for Molecular Detection of M\u00fcllerian Duct Carcinomas: A Proof-of-Concept Study","volume":"33","author":"Maritschnegg","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap8793","article-title":"Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers","volume":"10","author":"Wang","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2025.112617_bib28","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.7150\/jca.49647","article-title":"Combined assay of Circulating Tumor DNA and Protein Biomarkers for early noninvasive detection and prognosis of Non-Small Cell Lung Cancer","volume":"12","author":"Yin","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.isci.2025.112617_bib29","doi-asserted-by":"crossref","first-page":"10202","DOI":"10.1073\/pnas.1704961114","article-title":"Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers","volume":"114","author":"Cohen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112617_bib30","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.2147\/CMAR.S197455","article-title":"Detection of a novel panel of somatic mutations in plasma cell-free DNA and its diagnostic value in hepatocellular carcinoma","volume":"11","author":"Xiong","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.isci.2025.112617_bib31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.112617_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2022.09.004","article-title":"Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer","volume":"46","author":"Chao","year":"2023","journal-title":"Biomed. J."},{"key":"10.1016\/j.isci.2025.112617_bib33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1515\/cclm-2023-0541","article-title":"Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomics","volume":"62","author":"Wang","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.isci.2025.112617_bib34","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3390\/life13081689","article-title":"Tumor Markers and Their Diagnostic Significance in Ovarian Cancer","volume":"13","author":"Matsas","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.isci.2025.112617_bib35","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1073\/pnas.0502178102","article-title":"Serum protein markers for early detection of ovarian cancer","volume":"102","author":"Mor","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112617_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292282","article-title":"The Role of Interleukin 6 (IL6), Cancer Antigen-125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients","volume":"18","author":"Muhammad","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.112617_bib37","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.2008.19.2484","article-title":"Development of a multimarker assay for early detection of ovarian cancer","volume":"28","author":"Yurkovetsky","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1515\/med-2017-0020","article-title":"Serum CA125, CA199 and CEA Combined Detection for Epithelial Ovarian Cancer Diagnosis: A Meta-analysis","volume":"12","author":"Guo","year":"2017","journal-title":"Open Med."},{"key":"10.1016\/j.isci.2025.112617_bib39","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.3390\/cancers12123730","article-title":"CA125 and Ovarian Cancer: A Comprehensive Review","volume":"12","author":"Charkhchi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2025.112617_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","article-title":"Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review","volume":"12","author":"Dochez","year":"2019","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.isci.2025.112617_bib41","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jcp.2004.018077","article-title":"The role of CA125 in clinical practice","volume":"58","author":"Moss","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.isci.2025.112617_bib42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5001\/omj.2016.68","article-title":"Evaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass","volume":"31","author":"Al Musalhi","year":"2016","journal-title":"Oman Med. J."},{"key":"10.1016\/j.isci.2025.112617_bib43","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1200\/JCO.2014.59.4945","article-title":"Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening","volume":"33","author":"Menon","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ygyno.2012.11.026","article-title":"Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome","volume":"128","author":"Sandri","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2019.10.014","article-title":"Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?","volume":"468","author":"Asante","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2025.112617_bib46","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1158\/1078-0432.CCR-15-1534","article-title":"Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients","volume":"22","author":"Wang","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2025.112617_bib47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-med-041316-085721","article-title":"Circulating Tumor DNA: Measurement and Clinical Utility","volume":"69","author":"Donaldson","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.isci.2025.112617_bib48","article-title":"Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer\/T cell lymphoma","volume":"4","author":"Tian","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.112617_bib49","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1038\/ncomms8686","article-title":"Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients","volume":"6","author":"Sausen","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112617_bib50","article-title":"CLAmp-seq: A Novel Amplicon-Based NGS Assay with Concatemer Error Correction for Improved Detection of Actionable Mutations in Plasma cfDNA from Patients with NSCLC","volume":"4","author":"Wang","year":"2020","journal-title":"Small Methods"},{"key":"10.1016\/j.isci.2025.112617_bib51","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ijc.32586","article-title":"Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma","volume":"146","author":"Strijker","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.isci.2025.112617_bib52","article-title":"Mucinous cancer of the ovary: overview and current status","volume":"10","author":"Babaier","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.isci.2025.112617_bib53","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.3802\/jgo.2019.30.e32","article-title":"Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma","volume":"30","author":"Kim","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib54","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/1878-0261.12672","article-title":"Concordance between TP53 alterations in blood and tissue: impact of time interval, biopsy site, cancer type and circulating tumor DNA burden","volume":"14","author":"Bieg-Bourne","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104222","article-title":"Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer","volume":"83","author":"Liang","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2025.112617_bib56","article-title":"Molecular Biomarkers for the Early Detection of Ovarian Cancer","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.112617_bib57","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib58","first-page":"14141","article-title":"Early diagonosis of ovarian cancer: serum HE4, CA125 and ROMA model","volume":"13","author":"Wang","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.isci.2025.112617_bib59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2012.09.034","article-title":"The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass","volume":"128","author":"Chan","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib60","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1038\/s41467-018-06434-4","article-title":"Integrated extracellular microRNA profiling for ovarian cancer screening","volume":"9","author":"Yokoi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112617_bib61","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ygyno.2020.11.018","article-title":"Candidate RNA biomarkers in biofluids for early diagnosis of ovarian cancer: A systematic review","volume":"160","author":"Hulstaert","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2025.112617_bib62","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ijc.34757","article-title":"Plasma cell-free DNA methylation analysis for ovarian cancer detection: Analysis of samples from a case-control study and an ovarian cancer screening trial","volume":"154","author":"Herzog","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.isci.2025.112617_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.humrep.a136832","article-title":"The CA 125 tumour-associated antigen: a review of the literature","volume":"4","author":"Jacobs","year":"1989","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.isci.2025.112617_bib64","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/s41375-020-0869-y","article-title":"Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders","volume":"34","author":"Midic","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2025.112617_bib65","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1093\/bioinformatics\/btu314","article-title":"SAMBLASTER: fast duplicate marking and structural variant read extraction","volume":"30","author":"Faust","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2025.112617_bib66","article-title":"Haplotype-based variant detection from short-read sequencing","author":"Garrison","year":"2012","journal-title":"arXiv"},{"key":"10.1016\/j.isci.2025.112617_bib67","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2025.112617_bib68","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2025.112617_bib69","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2025.112617_bib70","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225008788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225008788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:36:48Z","timestamp":1768963008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225008788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2589004225008788"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.112617","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-analyte approach combining cfDNA sequencing and protein testing for early ovarian cancer detection","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.112617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112617"}}